You can buy or sell AMRX and other stocks, options, ETFs, and crypto commission-free!
Amneal Pharmaceuticals, Inc. Class A Common Stock, also called Amneal Pharmaceuticals, is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. Read More It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.
Bridgewater, New Jersey
52 Week High
52 Week Low
Guru FocusMar 12
Amneal Pharmaceuticals Inc (AMRX) President and CEO Robert A Stewart Bought $202,640 of Shares
President and CEO of Amneal Pharmaceuticals Inc (NYSE:AMRX) Robert A Stewart bought 17,000 shares of AMRX on 03/12/2019 at an average price of $11.92 a share.
PR NewswireMar 12
Amneal Announces Launch of Rivastigmine Transdermal System
BRIDGEWATER, N.J., March 12, 2019 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has launched its generic version of Exelon® Patch (Rivastigmine Transdermal System), 4.6 mg/24 hours, 9.5 mg/24 hours, and 13.3 mg/24 hours. The Company received FDA approval of its Rivastigmine Transdermal System in January 2019, and has received final approval on 10 Abbreviated New Drug Applications this year. "We are pleased to have received approval on and launched the company's first tr...
PR NewswireMar 6
Amneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference
BRIDGEWATER, N.J., March 6, 2019 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members of management will participate in a fireside chat at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami on Wednesday, March 13, 2019. To access a live webcast of the presentation, visit Amneal's Investor Relations Web site at https://investors.amneal.com. The webcast can also be accessed at the following URL: https://cc.talkpoint.com/barc002/031219a_as/?enti...
Available May 9, Pre-Market